Data on 984 stable coronary heart disease patients showed those with the highest high-sensitivity cardiac troponin-T levels were more than five times as likely as those with the lowest levels to suffer myocardial infarction, hospitalization for heart failure or cardiovascular death. "These findings suggest that hs-cTnT levels quantify an element of risk that is not captured by existing measures of cardiovascular disease severity," the authors wrote in JAMA: Internal Medicine.
Test could help predict secondary cardiovascular risk, study finds
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore